Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Malaria during pregnancy is a major global health problem caused by infection with Plasmodium falciparum parasites. Severe effects arise from the accumulation of infected erythrocytes in the placenta. Here, erythrocytes infected by late blood-stage parasites adhere to placental chondroitin sulphate A (CS) via VAR2CSA-type P. falciparum erythrocyte membrane protein 1 (PfEMP1) adhesion proteins. Immunity to placental malaria is acquired through exposure and mediated through antibodies to VAR2CSA. Through evolution, the VAR2CSA proteins have diversified in sequence to escape immune recognition but retained their overall macromolecular structure to maintain CS binding affinity. This structural conservation may also have allowed development of broadly reactive antibodies to VAR2CSA in immune women. Here we show the negative stain and cryo-EM structure of the only known broadly reactive human monoclonal antibody, PAM1.4, in complex with VAR2CSA. The data shows how PAM1.4’s broad VAR2CSA reactivity is achieved through interactions with multiple conserved residues of different sub-domains forming conformational epitope distant from the CS binding site on the VAR2CSA core structure. Thus, while PAM1.4 may represent a class of antibodies mediating placental malaria immunity by inducing phagocytosis or NK cell-mediated cytotoxicity, it is likely that broadly CS binding-inhibitory antibodies target other epitopes at the CS binding site. Insights on both types of broadly reactive monoclonal antibodies may aid the development of a vaccine against placental malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig 4 PAM1.4 Fab interaction analysis to ID1 and DBL4. Binding plot analysis using Ligplot+ v.2.7. Hydrogen bonds are shown in green dotted lines, electrostatic interactions in red dotted lines and hydrophobic contacts are shown as short spokes radiating from each atom or residue. Sequence conservation of PAM1.4-interacting amino acids in FCR3 VAR2CSA is shown in sequence LOGOs extracted from a previously published sequence alignment LOGO of 3737 VAR2CSA variants found in [13]. FCR3 VAR2CSA sequence positions 510 and 1614 correspond to alignment positions 523 and 1760 respectively. Representation of corresponding Ligplot+ in UCSFChimeraX showing ID1 and DBL4 interactions to Heavy and light chain CDRs of PAM1.4 Fab. Hydrogen bonds are represented in dotted blue lines. Non-CDR residue N93 of heavy chain is shown to form hydrogen bond with N1615 of DBL4 domain in VAR2CSA.](https://figures.cochat.ai/paper-figures/a9600dd70c714599a9e6f59b7ae19f5a/cryo-em-reveals-the-conformational-epitope-of-human-monoclonal-antibody-pam1-4-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The work by Raghavan and colleagues [11] provides evidence that they include discontinuous epitopes only displayed by the full-length VAR2CSA ectodomain.”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, an in-depth characterization of this human monoclonal antibody revealed that PAM1.4 binds a highly conserved conformational epitope involving residues in the ID1, DBL2, ID2, and DBL4 domains of VAR2CSA [11].”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“However, ID1 residues were semiconserved with residues K510-R511 (KR) of FCR3 VAR2CSA absent from 24% of the analyzed VAR2CSA variant sequences [11].”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“The in silico analysis of sequence conservation (among the amino acid residues involved in this conformational epitope) indicated that residues in DBL2, ID2, and DBL4 fragments of VAR2CSA are relatively conserved”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“with residues Y958 and R959 in FCR3 DBL2 the least conserved contact residues with PAM1.4.”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764 · cited 1×
“4 Fab, initial model was generated by alpha-fold2-multimer [54].”
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915 · cited 1×
“4 Fab was done iteratively using COOT [55] followed by real space refinement in PHENIX package [56].”
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115 · cited 1×
“Validation of model coordinates was performed in MolProbity [57] and is reported in S1 Table.”
WebLogo: A Sequence Logo Generator: Figure 1
Crooks, G. E., Hon, G., Chandonia, J.-M., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,386
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,514 · cited 2×
“Structure figures were generated using PyMOL (Version 2.1 Schrodinger, LLC) or UCSF Chi-meraX [52, 58, 59].”
InfluentialLigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
Laskowski, R. A., & Swindells, M. B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,471 · cited 1×
“The interacting residues and the figures for hydrogen bonds, electrostatic and hydrophobic interactions were generated using Ligplot + [60].”
Automated electron microscope tomography using robust prediction of specimen movements
Mastronarde, D. N. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.07.007 · Cited by 5,336 · cited 1×
“Raw Micrographs were recorded in TALOS Arctica 200kV (Thermo Fisher Scientific) with Falcon III direct electron detector (Thermo Fisher Scientific) at room temperature using Seri-alEM 3.7 [65].”
InfluentialCTFFIND4: Fast and accurate defocus estimation from electron micrographs
Rohou, A., & Grigorieff, N. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.08.008 · Cited by 4,913
Real-space refinement in PHENIX for cryo-EM and crystallography
Afonine, P. V., Poon, B. K., Read, R. J., Sobolev, O. V., Terwilliger, T. C., Urzhumtsev, A., & Adams, P. D. (2018) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798318006551 · Cited by 3,281
Ligand docking and binding site analysis with PyMOL and Autodock/Vina
Seeliger, D., & de Groot, B. L. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9352-6 · Cited by 2,623
The pathogenic basis of malaria
Miller, L. H., Baruch, D. I., Marsh, K., & Doumbo, O. K. (2002) · Nature · doi:10.1038/415673a · Cited by 1,746
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K., Larsen, C., Zheng, N.-Y., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,025
Visualizing density maps with UCSF Chimera
Goddard, T. D., Huang, C. C., & Ferrin, T. E. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.06.010 · Cited by 867
Flexible Fitting of Atomic Structures into Electron Microscopy Maps Using Molecular Dynamics
Trabuco, L. G., Villa, E., Mitra, K., Frank, J., & Schulten, K. (2008) · Structure · doi:10.1016/j.str.2008.03.005 · Cited by 864
Barnes, C. O., West, A. P., Huey-Tubman, K. E., Hoffmann, M. A. G., Sharaf, N. G., Hoffman, P. R., Koranda, N., Gristick, H. B., Gaebler, C., Muecksch, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.025 · Cited by 795 · cited 1×
“This technique has been developed to discern the polyclonal responses in non-human primates to vaccination with HIV immunogens and was used to assess the polyclonal human antibody response after vaccination against or infection with COVID-19 [40, 41].”
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
Self-citationMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659 · cited 1×
“Immunity is likely mediated by antibodies inhibiting VAR2CSA binding to placental CSA [17] and opsonizing VAR2CSA + infected erythrocytes for cell-mediated destruction [18–20].”
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628 · cited 1×
“4 broadly reactingwith malarialprotein VAR2CSA immunity to placental malaria [36].”
Self-citationEvidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Self-citationAfucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science · doi:10.1126/science.abc8378 · Cited by 408
Plasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer
Rask, T. S., Hansen, D. A., Theander, T. G., Gorm Pedersen, A., & Lavstsen, T. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000933 · Cited by 372
Self-citationBurden, pathology, and costs of malaria in pregnancy: new developments for an old problem
Rogerson, S. J., Desai, M., Mayor, A., Sicuri, E., Taylor, S. M., & van Eijk, A. M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30066-5 · Cited by 306 · cited 1×
“The VAR2CSA protein family is considered the main target of antibodies protecting women from adverse events due to P . falciparum infection during pregnancy [11, 34].”
Ehrenmann, F., Kaas, Q., & Lefranc, M.-P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp946 · Cited by 281 · cited 1×
“Antibody sequence analysis was performed using the IMGT (International ImMunoGeneTics information system)/V-QUEST (V-QUEry and STandardization) tool and database [63].”
Duffy, P. E., & Fried, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6620-6623.2003 · Cited by 260
Smith, J. D., Rowe, J. A., Higgins, M. K., & Lavstsen, T. (2013) · Cellular Microbiology · doi:10.1111/cmi.12183 · Cited by 225 · cited 1×
“…that can bind to endothelial receptors such as Endothelial Protein C Receptor (EPCR), Intracellular Adhesion Molecule 1 (ICAM-1) or CD36, which has been associated with severe malaria in immunologically na ï ve hosts (children) and asymptomatic infections in semi-immune hosts, respectively [7].”
Self-citationBianchi, M., Turner, H. L., Nogal, B., Cottrell, C. A., Oyen, D., Pauthner, M., Bastidas, R., Nedellec, R., McCoy, L. E., Wilson, I. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.009 · Cited by 205 · cited 1×
“Method was adopted from [64] and the data collection parameters are detailed in S2 Table.”
(2015) · Advances in Parasitology · doi:10.1016/bs.apar.2015.02.004 · Cited by 162 · cited 1×
“The tissue sequestration of infected erythrocytes is mediated by members of the P . falciparum Erythrocyte Membrane Protein 1 (PfEMP1) family [5] which has expanded to confer several mutually exclusive receptor binding phenotypes and diversified in sequence to avoid immune recognition (antigenic…”
Self-citationHigh resolution single particle refinement in EMAN2.1
Bell, J. M., Chen, M., Baldwin, P. R., & Ludtke, S. J. (2016) · Methods · doi:10.1016/j.ymeth.2016.02.018 · Cited by 156
Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154 · cited 1×
“However, these vaccine candidates induced only low titres of antibodies and very limited cross-reactivity in human phase I clinical trials [11, 24, 25].”
Self-citationSirima, S. B., Richert, L., Chêne, A., Konate, A. T., Campion, C., Dechavanne, S., Semblat, J.-P., Benhamouda, N., Bahuaud, M., Loulergue, P., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30739-x · Cited by 124
Barfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110 · cited 4×
“4 has been previously characterized [26].”
InfluentialSelf-citationProtective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Ndam, N. T., Denoeud-Ndam, L., Doritchamou, J., Viwami, F., Salanti, A., Nielsen, M. A., Fievet, N., Massougbodji, A., Luty, A. J. F., & Deloron, P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2105.141626 · Cited by 98
Self-citationShi, B., Ma, L., He, X., Wang, X., Wang, P., Zhou, L., & Yao, X. (2014) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-11-30 · Cited by 93 · cited 1×
“Also, the observed CDR lengths (e.g. VH CDR3 = 16 amino acid residues) are as typically seen for human IgG [33].”
HIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites
Keen, J., Serghides, L., Ayi, K., Patel, S. N., Ayisi, J., van Eijk, A., Steketee, R., Udhayakumar, V., & Kain, K. C. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040181 · Cited by 92
Evolutionary analysis of the most polymorphic gene family in falciparum malaria
Otto, T. D., Assefa, S. A., Böhme, U., Sanders, M. J., Kwiatkowski, D. P., Pf3k consortium, Berriman, M., & Newbold, C. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15590.1 · Cited by 90
Sander, A. F., Salanti, A., Lavstsen, T., Nielsen, M. A., Magistrado-Coxen, P., Lusingu, J., Ndam, N. T., & Arnot, D. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006667 · Cited by 75 · cited 1×
“Each parasite genome typically encodes one or two VAR2CSA variants with ectodomains differing in sequence within and among genomes [6, 10].”
Self-citationPregnancy-associated malaria in a rural community of ghana.
Ofori, M. F., Ansah, E., Agyepong, I. A., Ofori‐Adjei, D., Hviid, L., & Akanmori, B. D. (2009) · PubMed · Cited by 74
Self-citationStructural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.
Ma, R., Lian, T., Huang, R., Renn, J. P., Petersen, J. D., Zimmerberg, J., Duffy, P. E., & Tolia, N. H. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00858-9 · Cited by 72 · cited 1×
“These studies recently culminated in the molecular resolution data of the interaction of the full ectodomain VAR2CSA protein variants with CS [12– 14].”
Larsen, M. D., Lopez-Perez, M., Dickson, E. K., Ampomah, P., Ndam, N. T., Nouta, J., Koeleman, C. A. M., Ederveen, A. L. H., Mordmüller, B. G., Salanti, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26118-w · Cited by 67
Self-citationBarfod, L., Dobrilovic, T., Magistrado, P., Khunrae, P., Viwami, F., Bruun, J., Dahlbäck, M., Bernasconi, N. L., Fried, M., John, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002390 · Cited by 62 · cited 3×
“4 has shown broad reactivity across the VAR2CSA-type PfEMP1 [29].”
Self-citationHan, J., Schmitz, A. J., Richey, S. T., Dai, Y.-N., Turner, H. L., Mohammed, B. M., Fremont, D. H., Ellebedy, A. H., & Ward, A. B. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108682 · Cited by 60
Megnekou, R., Staalsoe, T., Taylor, D. W., Leke, R., & Hviid, L. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.4112-4118.2005 · Cited by 57 · cited 1×
“Indeed, acquired antibodies to VAR2CSA are mainly cyto-philic [37] and importantly are markedly afucosylated [18].”
Self-citationNielsen, M. A., Resende, M., de Jongh, W. A., Ditlev, S. B., Mordmüller, B. G., Houard, S. A., Ndam, N. T., Agerbæk, M. Ø., Hamborg, M., Massougbodji, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135406 · Cited by 54 · cited 1×
“Vaccination of rodents with truncated VAR2CSA proteins can elicit antibodies that inhibit diverse VAR2CSA variants like antibodies from naturally VAR2CSA-exposed women [22, 23].”
Self-citationWang, K., Dagil, R., Lavstsen, T., Misra, S. K., Spliid, C. B., Wang, Y., Gustavsson, T., Sandoval, D. R., Vidal-Calvo, E. E., Choudhary, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23254-1 · Cited by 52
Self-citationProgress and Insights Toward an Effective Placental Malaria Vaccine
Gamain, B., Chêne, A., Viebig, N. K., Ndam, N. T., & Nielsen, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634508 · Cited by 46 · cited 3×
“The VAR2CSA protein family is considered the main target of antibodies protecting women from adverse events due to P . falciparum infection during pregnancy [11, 34].”
Self-citationSampaio, N. G., Eriksson, E. M., & Schofield, L. (2017) · Infection and Immunity · doi:10.1128/iai.00447-17 · Cited by 40 · cited 1×
“4, appears to recognize all (or at least most) native VAR2CSA variants [26–28].”
Larsen, M. D., Quintana, M. D. P., Ditlev, S. B., Bayarri‐Olmos, R., Ofori, M. F., Hviid, L., & Garred, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03088 · Cited by 37 · cited 1×
“4 was produced as recombinant secreted protein in suspension-adapted Human Embryonic Kidney cells (Expi293F Gibco), as described in [45].”
Self-citationAmpomah, P., Stevenson, L., Ofori, M. F., Barfod, L. K., & Hviid, L. (2014) · Infection and Immunity · doi:10.1128/iai.01514-13 · Cited by 36 · cited 1×
“Folding of the proteins was assessed by confirming CSPG binding and by reactivity of serum from placental malaria-PLOS exposed Tanzanian [42] and Ghanaian (N = 20) women [43, 44] and Ghanaian male adults (S10 Fig).”
Self-citationPreclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
Chêne, A., Gangnard, S., Guadall, A., Ginisty, H., Leroy, O. Y., Havelange, N., Viebig, N. K., & Gamain, B. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.010 · Cited by 36
Doritchamou, J. Y. A., Herrera, R., Aebig, J. A., Morrison, R., Nguyen, V., Reiter, K., Shimp, R. L., MacDonald, N. J., Narum, D. L., Fried, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw197 · Cited by 35 · cited 1×
“In support of this, a recent paper showed that human VAR2CSA (polyclonal) IgG could be depleted from human sera by a single full-length VAR2CSA ectodomain [21] but not by individual VAR2CSA domains [35].”
Doritchamou, J. Y. A., Morrison, R., Renn, J. P., Ribeiro, J., Duan, J., Fried, M., & Duffy, P. E. (2019) · Communications Biology · doi:10.1038/s42003-019-0704-z · Cited by 31 · cited 1×
“4 in their native form (NF54, FCR3, 7G8 and M200101 [27]), represent the observed sequence diversity in position 510–511.”
Hjort, L., Møller, S. L., Minja, D. T. R., Msemo, O. A., Nielsen, B. B., Christensen, D. L., Theander, T. G., Nielsen, K. B., Larsen, L. G., Grunnet, L. G., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024861 · Cited by 25 · cited 1×
“Folding of the proteins was assessed by confirming CSPG binding and by reactivity of serum from placental malaria-PLOS exposed Tanzanian [42] and Ghanaian (N = 20) women [43, 44] and Ghanaian male adults (S10 Fig).”
Self-citationRenn, J. P., Doritchamou, J. Y. A., Tentokam, B. C. N., Morrison, R. D., Cowles, M. V., Burkhardt, M., Ma, R., Mahamar, A., Attaher, O., Diarra, B. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02787-7 · Cited by 24 · cited 2×
“4 is unable to inhibit infected erythrocyte adhesion to CS [30].”
Doritchamou, J. Y., Renn, J. P., Jenkins, B., Mahamar, A., Dicko, A., Fried, M., & Duffy, P. E. (2022) · eLife · doi:10.7554/elife.76264 · Cited by 23
Doritchamou, J., Sabbagh, A., Jespersen, J. S., Renard, E., Salanti, A., Nielsen, M. A., Deloron, P., & Tuikue Ndam, N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137695 · Cited by 22
Self-citationNo sweet deal: the antibody-mediated immune response to malaria
Hviid, L., Lopez-Perez, M., Larsen, M. D., & Vidarsson, G. (2022) · Trends in Parasitology · doi:10.1016/j.pt.2022.02.008 · Cited by 20 · cited 1×
“Immunity is likely mediated by antibodies inhibiting VAR2CSA binding to placental CSA [17] and opsonizing VAR2CSA + infected erythrocytes for cell-mediated destruction [18–20].”
Self-citationWang, W., Wang, Z., Yang, X., Gao, Y., Zhang, X., Wang, W., Zhao, L., zhang, J., Jing, Q., Xu, Q., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00324-8 · Cited by 19 · cited 1×
“These studies recently culminated in the molecular resolution data of the interaction of the full ectodomain VAR2CSA protein variants with CS [12– 14].”
Analysis of CSA-Binding Parasites and Antiadhesion Antibodies
Fried, M., & Duffy, P. E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-271-6:555 · Cited by 12 · cited 1×
“Static adhesion assays were employed to evaluate the capacity of human antibodies to inhibit the infected erythrocyte adhesion to CS, as described elsewhere [47, 48].”
PfEMP1-Specific Immunoglobulin G Reactivity Among Beninese Pregnant Women With Sickle Cell Trait
Lopez-Perez, M., Viwami, F., Seidu, Z., Jensen, A. T. R., Doritchamou, J., Ndam, N. T., & Hviid, L. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab527 · Cited by 11 · cited 1×
“Static adhesion assays were employed to evaluate the capacity of human antibodies to inhibit the infected erythrocyte adhesion to CS, as described elsewhere [47, 48].”
Self-citationLopez-Perez, M., & Olsen, R. W. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_7 · Cited by 10
Self-citationmSphere of Influence: Structural Insights into the Molecular Mechanism Underlying Placental Malaria
Quintana, M. D. P. (2021) · mSphere · doi:10.1128/msphere.00391-21 · Cited by 2 · cited 1×
“The structural resolution of VAR2CSA has raised hopes that novel immunogen and vaccine strategies for boosting cross-reactive responses can be designed [39].”
Self-citation
Research works printed but not linked: 1
- L Barfod, 2007, Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA, MolMicrobiol, 63, 335
Cited by
Hviid, L., Jensen, A. T. R., & Deitsch, K. (2024) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2024.02.001 · Cited by 26
Self-citationMa, R., Salinas, N. D., Orr-Gonzalez, S., Richardson, B., Ouahes, T., Torano, H., Jenkins, B. J., Dickey, T. H., Neal, J., Duan, J., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011879 · Cited by 12
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
Doritchamou, J. Y. A., Renn, J. P., Hviid, L., & Duffy, P. E. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011370 · Cited by 8
Self-citationMalaria in pregnancy at the frontline: a delicate balance
Kokuhennadige, V., Aitken, E. H., & Rogerson, S. J. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102726 · Cited by 8
Sayeed, M. A., Nabil, I. K., Bhattacharjee, P., Hossain, M. S., Akter, N. J., Akter, R., Kelley, K. L., Karim, M., Begum, Y. A., Bhuiyan, T. R., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01443-24 · Cited by 4
“Alternatively, a new suite of mAbs to ORF122 protein could be generated and epitope location could be validated with cryo-electron microscopy (38, 39).”
Metadata
- Authors
- Raghavan, S. S. R., Dagil, R., Lopez-Perez, M., Conrad, J., Bassi, M. R., Quintana, M. D. P., Choudhary, S., Gustavsson, T., Wang, Y., Gourdon, P., Ofori, M. F., Christensen, S. B., Minja, D. T. R., Schmiegelow, C., Nielsen, M. A., Barfod, L., Hviid, L., Salanti, A., Lavstsen, T., & Wang, K.
- Affiliations
- University of Copenhagen (DK)
- Science for Life Laboratory (SE)
- Zhejiang University-University of Edinburgh Institute (CN)
- University of Ghana (GH)
- National Institute for Medical Research (TZ)
- Corresponding author
- Lavstsen, Thomas
- Wang, Kaituo
- ORCID
- Raghavan, Sai Sundar Rajan
- Dagil, Robert
- Lopez-Perez, Mary
- Conrad, Julian
- Bassi, Maria Rosaria
- Choudhary, Swati
- Gustavsson, Tobias
- Wang, Yong
- Gourdon, Pontus
- Ofori, Michael Fokuo
- Minja, Daniel Thomas Remias
- Schmiegelow, Christentze
- Nielsen, Morten Agertoug
- Barfod, Lea
- Hviid, Lars
- Salanti, Ali
- Lavstsen, Thomas
- Wang, Kaituo
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-11-16
- Volume
- 18
- Issue
- 11
- Pages
- e1010924
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC9668162
- OpenAlex
- W4309139082
- Cited by
- 14
- References
- 64
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 6 · 2023: 2
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- The Lundbeck Foundation (R344-2020-934)
- Independent Research Fund Denmark (9039-00285A, 0134-00123B, 1030-00371B)
- Danida (17-02 KU)
- National Institutes of Health (R21AI164147-01)
- EU (101028915)
- Novo Nordisk Foundation (NNF170C0026778)
- Novo Nordisk Fonden (NNF21OC0068192 and NNF22OC0076055)
- Carlsberg Foundation (Semper Ardens Grant)
- Global Health Innovative Technology Fund (G2020-214)
- European Union Advance-vac4PM (101057882)
- The Danish Council for Strategic Research (1309- 00003B)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- VAR2CSA, PfEMP1, placental malaria, Plasmodium falciparum, conformational epitopes, chondroitin sulfate A, placental adhesions, antibody-antigen complex structure, malaria vaccine, placental immunity
- MeSH terms
- Antibodies, Monoclonal, Antibodies, Protozoan, Epitopes, Antigens, Protozoan, Chondroitin Sulfates, Erythrocytes, Female, Humans, Malaria, Placenta, Plasmodium falciparum, Pregnancy, Malaria, Falciparum, Cryoelectron Microscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.